Study of p53 codon 72 polymorphism and codon 249 mutations in Southern India in relation to age, alcohol drinking and smoking habits

Human and Experimental Toxicology

Volumn 29, Issue 6, 2010, Pages 451-458

  Pandima Devi, K ^a   Sivamaruthi, B ^a   Kiruthiga, P V ^a   Karutha Pandian, S ^a  

^a ALAGAPPA UNIVERSITY   (India)

Author keywords

Codon 249; Codon 72; P53 gene; Polymorphism; Smokers

Indexed keywords

ARGININE; PROLINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CODON; CONTROLLED STUDY; DRINKING BEHAVIOR; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INDIA; LUNG CANCER; LUNG CARCINOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SMOKING HABIT; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGING; ALCOHOL DRINKING; CODON; EXONS; GENE FREQUENCY; GENES, P53; GENETIC ASSOCIATION STUDIES; HUMANS; INDIA; LUNG NEOPLASMS; MIDDLE AGED; MUTATION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RESTRICTION MAPPING; RISK FACTORS; SMOKING; YOUNG ADULT;

NICOTIANA TABACUM;

EID: 77952274191     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327109354938     Document Type: Article

References (33)

1. Campisi J. Between Scylla and Charybdis: p53 links tumor suppression and aging. Mech Ageing Dev 2002 ; 123: 567-573.
2. Fan R., Wu MT, Miller D., et al. The p53 codon 72 polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2000 ; 9: 1037-1042.
3. Hollstein M., Sidransky D., Vogelstein B., Harris CC p53 mutations in human cancers. Science 1991 ; 253: 49-53.
4. Greenblatt MS, Bennett WP, Hollstein H., Harris CC Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994 ; 54: 4855-4878.
5. Hussain SP, Harris CC Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res 1998 ; 58: 4023-4037.
6. Myers S., Ali MY Determination of tobacco specific hemoglobin adducts in smoking mothers and new born babies by mass spectrometry. Biomark Insights 2007 ; 2: 269-282.
7. Carbone D. Smoking and cancer. Am J Med 1992 ; 93: 13-17.
8. Hu Y., McDermott MP, Ahrendt SA The p53 codon 72 proline allele is associatedwith p53 gene mutations in non-small cell lung cancer. Clin Cancer Res 2005 ; 11: 2502-2509.
9. Chosdol K., Ahuja A., Rathore A., et al. Study of p53 codon 72 polymorphism in various ethnic groups of North India. Curr Sci 2002 ; 82: 1253-1255.
10. Huang XH, Sun LH, Lu DD, et al. Codon 249 mutation in exon 7 of p53 gene in plasma DNA: may be a new early diagnostic marker of hepatocellular carcinoma in Qidong risk area, China. World J Gastroenterol 2003 ; 9: 692-695.
11. Hussain SP, Amstad P., Raja K., et al. Mutability of p53 hotspot codons to benzo(a)pyrene diol epoxide (BPDE) and the frequency of p53 mutations in nontumorous human lung. Cancer Res 2001 ; 61: 6350-6355.
12. Lopez AD Measuring the health hazards of tobacco: commentary. Bull WHO 1999 ; 77: 82-83.
13. Cairns J. Mutation and cancer: The antecedents to our studies of adaptive mutation.
14. Hecht SS Tobacco smoke carcinogens. J Natl Cancer Inst 1999 ; 21: 1194-2010.
15. Rodin SN, Rodin AS On the origin of p53 G:Cĝ†'T:A transversions in lung cancers. Mutat Res 2002 ; 508: 1-19.
16. Jeffreys AJ, Morton DB DNA fingerprints of dogs and cats. Anim Genet 1987 ; 18: 1-15.
17. Wang Y. -C, Lee H. -S, Chen S. -K, Chang Y. -Y, Chen C. -Y. Prognostic significance of p53 codon 72 polymorphism in lung carcinomas. Eur J Cancer 1999 ; 35: 226-230.
18. Pezeshki A., Aslani FS, Ghaderi A., Doroudchi M. p53 Codon 72 polymorphism in basal cell carcinoma of the skin. Pathol Oncol Res 2006 ; 12: 29-33.
19. Jain N., Singh V., Hedau S., et al. Infection of human papillomavirus type 18 and p53 codon 72 polymorphism in lung cancer patients from India. Chest 2005 ; 128: 3999-4007.
20. Saranath D., Khan Z., Tandle AT, Dedhia P., Sharma B., Contractor R., Shrivastava S., dinshaw K. HPV16/ 18prevalence in cervical lesions/cancers and p53genotypes in cervical cancer patients from India. Gynecol Oncol 2002 ; 86 (2). 157-162.
21. Kim JW, Lee CG, Park YG, Kim KS, Kim IK Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: relation to the incidence rate of cervical carcinoma. Cancer 20008; 8: 2082-2091.
22. Klug SJ, Wilmette R., Santos C. TP53 polymorphism, HPV infection, and risk of cervical cancer. Cancer Epidemiol Biomarkers Prev; 2001 ; 10: 1009-1012.
23. Storey A., Thomas M., Kalita A., Harwood C., Gardiol D., Mantovani F. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998 ; 393: 229-234.
24. Kaname Kawajiri, Kei Nakachi, Kazue Imai, Junko Watanabe, Shin-Ichi Hayashi. Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer. Carcinogenesis 1993 ; 14: 1085-1089.
25. Tagawa M., Murata M., Kimura H. Prognostic value of mutations and a germ line polymorphism of the p53 gene in non-small cell lung carcinoma: association with clinicopathological features. Cancer Lett 1998 ; 128: 93-99.
26. Wang YC, Chen CY, Chen SK, Chang YY, Lin P. p53 Codon 72 Polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis. Clin Cancer Res 1999 ; 5: 129-134. (Pubitemid 29045185)
27. Jain N., Li Y., Zhang L., Meneni SR, Cho BP Probing the sequence effects on NarI-induced -2 frameshift mutagenesis by dynamic 19F NMR, UV, and CD spectroscopy. Biochemistry 2007 ; 46: 13310-13321.
28. Papadakis ED, Soulitzis N., Spandidos DA Association of p53 codon 72 polymorphism with advanced lung cancer: the Arg allele is preferentially retained in tumours arising in Arg/Pro germline heterozygotes. Br J Cancer 2002 ; 87: 1013-1018.
29. Jin X., Wu X., Roth JA, et al. Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype. Carcinogenesis 1995 ; 16: 2205-2208.
30. Miller DP, Liu G., Vivo ID, et al. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. Cancer Res 2002 ; 62: 2819-2823.
31. Pierce LM, Sivaraman L., Chang W., et al. Relationships of TP53 codon 72 and HRAS1 polymorphisms with lung cancer risk in an ethnically diverse population. Cancer Epidemiol Biomarkers Prev 2000 ; 9: 1199-1204.
32. Mou PX, Wei PW, Lu YJ Codon 249 mutations of p53 gene in development of hepatocellular carcinoma. World J Gastroenterol 1998 ; 4: 125-127.
33. Katiyar S., Dash BC, Thakur V., Guptan RC, Sarin SK, Das BC, P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India. American Cancer Society Nov 2000: 88 (7). 1565-1573.